AURKA and neoplasm: In addition, one tumor each had a NTRK3 fusion (ETV6-NTRK3), a PTEN deletion, an FGFR1 GOF mutation (K654E), a CHEK2 LOF mutation (T367fs*), and an Aurora kinase A fusion (AURKA-CSTF1).